Podcast Addict
App
Podcast promotion
العربية (Arabic)
中文 (Chinese)
Hrvatski (Croatian)
Čeština (Czech)
Dansk (Danish)
Nederlands (Dutch)
English
Eesti (Estonian)
Suomi (Finnish)
Français (French)
Deutsch (German)
Ελληνικά (Greek)
עברית (Hebrew)
हिन्दी (Hindi)
Magyar (Hungarian)
Bahasa Indonesia (Indonesian)
Italiano (Italian)
日本語 (Japanese)
한국어 (Korean)
Norsk (Norwegian)
فارسی (Persian)
Polski (Polish)
Português (Portuguese)
Русский (Russian)
Español (Spanish)
Svenska (Swedish)
Українська (Ukrainian)
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Key Points from the Adaura Trial: Osimertinib
1.0x
0% played
00:00
00:00
Nov 30 2023
6 mins
Other Episodes
Dr. Joshua Reuss examines important details learned during the ADAURA trial, including overall survival, reduced risk of brain mets, and side effects.
Download episode
Share
Share
Copy URL
Subscribe on Podcast Addict